prostatic cancer

Authors and affiliations:
João Ramalho-Carvalho^1,2,3, Inês Graça^1,4, Antonio Gomez^2,#, Jorge Oliveira⁵, Rui Henrique^2,6,7, Manel Esteller^2,8,9,*, and Carmen Jerónimo^{1,7,*, ‡}

¹Cancer Biology & Epigenetics Group – Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal;